MJT & Associates Financial Advisory’s Ionis Pharmaceuticals IONS Stock Holding History

MJT & Associates Financial Advisory’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19K	Buy	+15	New	+$1.13K	﹤0.01%	414

Other funds holding IONS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

WMA

West Michigan Advisors Holland, Michigan $455M AUM 31.82% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MJT & Associates Financial Advisory's IONS Position: Q2 2026 in Review

MJT & Associates Financial Advisory opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 15 shares worth $1.19K. The stake represents ﹤0.01% of the portfolio and ranks #414 among its holdings.

84 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

MJT & Associates Financial Advisory held 15 shares of Ionis Pharmaceuticals worth $1.19K as of Q2 2026.
Ionis Pharmaceuticals was a new MJT & Associates Financial Advisory position in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q2 2026, its #414 holding.
84 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q2 2026, filed 6 Jul 2026.